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ABSTRACT 
Fourteen Cp*IrIII complexes bearing various combinations of N- and C- spectator ligands are assayed 
in hydrogen-transfer catalysis from iso-propanol to acetophenone under various conditions to investigate 
ligand effects in this widely used reaction. The new cationic complexes bearing monodentate pyridine 
and NHC ligands were characterized crystallographically and by VT-NMR. Control experiments and 
mercury poisoning tests showed that iridium(0) nanoparticles, although active in the reaction, are not 
responsible for the high activity observed for the most active precatalyst [Cp*Ir(IMe)2Cl]BF4 (6). 
Interestingly, for efficient catalysis it was found necessary to have both NHCs in monodentate form; 
tying them together in a bis-NHC chelate ligand gave greatly reduced activity. The kinetics of the base-
assisted reaction showed induction periods as well as deactivation processes, and H/D scrambling 
experiments cast some doubt on the classical monohydride mechanism. 
 
KEY WORDS 
Transfer hydrogenation, Cp*Ir complexes, N-heterocyclic carbenes, homogeneous catalysis, kinetics, 
mono-hydride mechanism. 
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INTRODUCTION 
Transfer hydrogenation is a useful reduction protocol increasing in popularity, in part because these 
reactions can be run using a variety of liquid or solid hydrogen donors without the need for hydrogen 
gas.1 Furthermore, the reversibility of the ionic H+/H- transfer2 forms the basis for many useful C-C, C-
O, and C-N bond forming reactions via ‘borrowing-hydrogen’ methodology.3-6 The first catalytic 
systems mediating hydrogen transfer reported by Mitchell and Henbest7-9 and Mestroni10 were based on 
iridium compounds, and iridium catalysts are still amongst the most widely used today.11 In the early 
2000s, Ikariya and Noyori12 and Fujita and Yamaguchi13 introduced half-sandwich Cp*Ir complexes 
(including chiral versions14-16) as easily accessible and versatile precatalysts, which have quickly found 
wide use.17 More recently, some Cp*Ir-NHC complexes (NHC = N-heterocyclic carbene) have been 
shown to be particularly effective.18-20 Several Cp*Ir precatalysts are currently commercially available, 
and the first examples are moving towards industrial application.21 
The commonly accepted mechanism of Cp*Ir-catalyzed hydrogen transfer follows the ‘monohydride 
route’ assuming full retention of all ancillary ligands.22 Although this pathway represents a reasonable 
scenario in analogy with other transition-metal based catalysts it fails to fully account for the influence 
of ligand effects in the Cp*Ir precursors,23 partly because the kinetics are still rather poorly understood. 
Here we present a systematic study of a small library of Cp*Ir complexes with non-functional24 C- and 
N- donor spectator ligands in hydrogen-transfer catalysis to investigate ligand effects in this important 
transformation. In this paper, we focus on the effect of the ancillary ligands around the Cp*Ir fragment 
while in a future contribution we will look at the role of the Cp* ligand. A highlight of the present work 
is the development of a new, highly active Cp*Ir precatalyst that may follow a different mechanism 
from that commonly assumed for this type of precursor. 
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RESULTS AND DISCUSSION 
Complexes 1-14 (Figure 1) were designed as catalyst precursors to probe the influence of pyridines 
versus NHCs (1 vs. 2 vs. 3, 4 vs. 5 vs. 6, 8 vs. 10 vs. 11), chelating versus mono-dentate (4 vs. 11, 5 vs. 
10, 6 vs. 8), LL-type versus LX-type (10 vs. 13, 11 vs. 14), and remote pH-switchable ligands (10 vs. 
12). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Cp*IrIII complexes evaluated in transfer-hydrogenation catalysis. 
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The reactivity switch of Ag-NHC complexes from mono-NHC transfer to bis-NHC transfer as a 
function of the coordination ability of the anion described previously for transmetalation reactions with 
RhI and IrI complexes25 was also found to apply to [Cp*IrCl2]2, and allowed convenient access to mono- 
and bis-NHC complexes 3, 6, and 7, respectively (Scheme 1 and Figure 2). All other compounds were 
obtained via slight modifications of known procedures and isolated in good to excellent yields as air- 
and moisture-stable, crystalline solids after purification (see Experimental Section). 
  
Scheme 1. Single NHC transfer (left) versus double NHC transfer with anion metathesis (right) at 
[Cp*IrCl2]2 depending on the Ag-NHC complex used (Z = halide, X = weakly coordinating anion). 
 
Compounds 4, 5, 6, 7, 9, and 12 have been characterized by single-crystal X-ray diffraction (Figure 2) 
while crystal structures of 3,26 8,27 10,28 11,26 1329 and 1430 have been reported previously. In the solid 
state, all complexes have the expected piano-stool geometry without any unexpected features. As 
summarized in Table 1, ligand bite angles and bond lengths are very similar in the chelating and 
monodentate cationic complexes. 
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Figure 2. X-ray crystal structures of complexes 4, 5, 6, 7, 827 and 9 (counterions and solvent 
molecules omitted for clarity) 
 
Table 1. Comparison of selected structural data of Cp*Ir complexes in the solid state. 
complex Ir-L distances 
L-Ir-L 
angles 
4 2.08 Å (C), 2.16 Å (N) 87.3˚ 
 7 
5 2.16 Å 83.9˚ 
6 2.06 Å 86.1º 
7 2.05 Å 85.0º 
827 2.02 Å 86.4º 
9 2.04 Å 85.0º 
1028 2.10 Å 76.1º 
1126 2.02 Å (C), 2.10 Å (N) 85.4º 
1231 2.11 Å 75.4º 
1329 2.06 Å (C), 2.10 Å (N) 78.8º 
1430 2.00 Å (NHC), 2.05 Å (aryl) 77.6º 
 
 
In solution, both the pyridines and the minimally substituted IMe (1,3-dimethylimidazol-2-ylidene) 
and TMe (1,4-dimethyl-1,2,4-triazol-5-ylidene) ligands were found to rotate freely around the L-M axis 
on the NMR timescale at room temperature even in the bis-ligated complexes 4-7, indicating little steric 
hindrance. Variable-temperature 1H NMR at 500 MHz in CD2Cl2 showed decoalescence of the IMe 
signals in 6 below 223 K, and decoalescence of the TMe in 7 below 233 K (see Supporting 
Information). In the mixed py/IMe complex 4 the IMe ligand peaks split below 248 K, while the 
pyridine ligand gave one set of sharp peaks down to 193 K (see Supporting Information). 
 
Freshly purified complexes 1-14 were evaluated for activity in the transfer-hydrogenation of 
acetophenone at 1 mol% [Ir] loading after 3 hours in refluxing iPrOH (~82 ºC) under N2 (Scheme 2). 
Reactions were run in the presence of 10 mol% KOH, 2 mol% AgBF4, or without any additional 
promoter. Conversions were determined by 1H-NMR spectroscopy using 1,3,5-trimethoxybenzene as 
internal standard. 
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Scheme 2. Transfer-hydrogenation of acetophenone to rac-1-phenylethanol from excess iso-propanol. 
 
 
 
As can be seen from Figures 3-5, conversion to product varied widely depending on the conditions 
applied and precatalyst used. With the assistance of 10 mol% KOH, most precatalysts afforded 
significant conversion except complexes 8, 9, 12, and 14. Interestingly, the simple [Cp*IrCl2]2 precursor 
1 outperformed many of the more sophisticated Cp*Ir complexes, although 6 and 10 were clearly the 
most effective precatalysts under these conditions. Using Ag+ as activating agent instead of a base gave 
lower conversions and different trends in activity. Complexes 4 and 5, bearing a labile pyridine base, 
gave the best results of ~70 % conversion under these conditions. Attempted double-activation with 
KOH and AgBF4 gave virtually zero activity for all complexes (data not shown). A black precipitate 
formed in all of these reactions, suggesting in-situ formation of Ag2O that effectively removes both Ag+ 
and OH- from the solution. Without any additive, activities were very low (<5 %) for all precursors 
except 5 and 11 (~15% conversion), as expected for precursors with non-functional spectator ligands. 
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Figure 3. Activity of complexes 1-14 in the transfer-hydrogenation of acetophenone (Scheme 2). 
Reaction conditions: 2 mmol substrate, 1 mol% [Ir], 10 mol% KOH, 3 mL iPrOH, reflux, N2, 3 hours 
(1H NMR analysis with 1,3,5-trimethoxybenzene as internal standard, triplicates). 
 
 
 
 
 
 
 
Figure 4. Activity of complexes 1-14 in the transfer-hydrogenation of acetophenone (Scheme 2). 
Reaction conditions: 2 mmol substrate, 1 mol% [Ir], 2 mol% AgBF4, 3 mL iPrOH, reflux, N2, 3 hours 
(1H NMR analysis with 1,3,5-trimethoxybenzene as internal standard, duplicates). 
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Figure 5. Activity of complexes 1-14 in the transfer-hydrogenation of acetophenone (Scheme 2). 
Reaction conditions: 2 mmol substrate, 1 mol% [Ir], 3 mL iPrOH, reflux, N2, 3 hours (1H NMR analysis 
with 1,3,5-trimethoxybenzene as internal standard, duplicates). 
 
The base-assisted reactions were found to be sensitive to both oxygen and moisture. No conversion 
was observed when running the catalysis in air, and addition of 50 µL water (~140 eq. with respect to 
[Ir]) under N2 equally shut down all activity. The addition of activated 3Å MS to the reaction did not 
improve performance either, however. In acidic aqueous media (10-100 eq. HOTf or HClO4 in 1:1-10:1 
iPrOH/H2O) even the most active precursor 6 was completely inactivated, in contrast to aqueous 
hydrogen transfer reactions with Cp*Ir precatalysts using formate as the reductant, where optimum 
activity is typically observed in acidic media (pH~2 for NH4COOH, pH~3 for NaCOOH).32 
 
As the base-assisted reactions were the most efficient, we examined the background reactivity of KOH 
alone under our conditions. Transfer-hydrogenations of aldehydes and ketones are known to be slowly 
catalyzed by simple alkali metal bases,33-35 and even alcohol alkylations can be achieved with base 
only.36 Following activity over time showed that about 16 % phenylethanol was produced by 10 mol% 
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KOH after 3 hours at 80 ºC (Figure 6), indicating that complexes 8, 9, 12, 14 had effectively afforded 
zero activity (Figure 3). Lowering the temperature to 60 ºC gave much lower base-catalyzed activity of 
only ~2 % after 4 hours, and at 40 ºC no product could be observed by 1H NMR even after 12 hours. 
 
 
 
 
 
 
 
Figure 6. Background activity of KOH (10 mol%, semiconductor grade) in the transfer-hydrogenation 
of acetophenone at different temperatures (2 mmol substrate, 3 mL iPrOH, N2; 1H NMR analysis with 
1,3,5-trimethoxybenzene as internal standard; lines drawn to guide the eye). 
 
Next, some simple iridium compounds, including heterogeneous forms, were evaluated in the reaction 
to test for potential contributions from decomposition products of the Cp*Ir precursors (Table 2). 
Numerous heterogeneous catalysts,37 including IrO2,38 and various metal nanoparticles (NPs) are known 
to catalyze transfer-hydrogenations quite efficiently,39-44 and for some related iron and ruthenium 
complexes metallic NPs have recently been shown to contribute to catalytic activity.45,46 In-situ de-
ligation of molecular precursors to give heterogeneous material as the true active species is a persistent 
ambiguity in homogeneous catalysis often responsible for misleading ligand effects.47 
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Table 2. Activity of various iridium compounds in the transfer-hydrogenation of acetophenone 
(Scheme 2).a 
precatalyst with KOH no additive 
IrCl3 × 3 H2O 81 ± 2 % 7 ± 1 % 
IrO2 (powder)b 21 ± 3 % 0 % 
Ir/C (0.5 wt%)b 29 ± 11 % 0 % 
2-3 nm Ir0 NPs48 94 ± 6 % 4 ± 1 % 
 
a 2 mmol substrate, 1 mol% [Ir], 3 mL iPrOH, reflux, N2, 3 hours (1H NMR analysis with 1,3,5-trimethoxybenzene as 
internal standard, duplicates). b dried at 80 ˚C in vacuo for at least 3 hours prior to use. 
 
As expected from the early work of Mitchell and Henbest,9 IrCl3 hydrate afforded good activity with 
>80 % conversion in 3 hours, surpassing many of the Cp*Ir precursors under identical conditions (cf. 
Figure 3). While IrO2 and iridium on carbon barely added to the background activity of KOH, iridium(0) 
nanoparticles synthesized in-situ48 prior to catalysis were highly active in the presence of base (Table 2). 
These findings might at first appear indicative of Ir NPs being the true catalyst in all cases, with the 
activity trends merely reflecting the ease of reductive in-situ decomposition. We therefore ran reactions 
with Ir NPs, IrCl3, and 6 in the presence of excess Hg to selectively poison heterogeneous forms of 
metallic iridium49 (Table 3). While the preformed NPs were effectively deactivated by Hg, both IrCl3 
and 6 displayed virtually unperturbed activity in its presence, strongly suggesting genuine solution-phase 
catalysis in case of the molecular precursors.50 
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Table 3. Mercury poisoning test of different iridium precatalysts in the transfer-hydrogenation of 
acetophenone (Scheme 2).a 
precatalyst no Hg with Hg 
6 99 ± 1 % 98 ± 1 % 
IrCl3 × 3 H2O 39 ± 1 % 37 ± 1 % 
2-3 nm Ir NPs48 64 ± 1 % 5 ± 1 % 
 
a 2 mmol substrate, 1 mol% [Ir], 10 mol% KOH, 3 mL iPrOH, 60 ºC, N2, 3 hours (1H NMR analysis with 1,3,5-
trimethoxybenzene as internal standard). 
 
After having subtracted background reactivity of the base and provided evidence against in-situ 
decomposition into heterogeneous catalysts, we can discuss the activities of the most active precursors 
IrCl3, 1 – 6, and 10 in comparison with the less active ones. Clearly, both IMe and pyridine are good 
supporting ligands for Cp*Ir transfer-hydrogenation catalysts, but no obvious trends regarding ligand 
denticity, sterics, or electronics are apparent from this data set collected under strictly comparable 
conditions. For example, linking the two pyridines in 5 to give a bipy ligand in 10 slightly increases 
catalyst activity, whereas the same strategy has a much opposed effect in the case of two IMe in 6 versus 
8 or one IMe and one pyridine as in 4 versus 11. Also, going from IMe to TMe, a subtle change in 
electronics,51 dramatically decreases catalyst activity in 7 as compared to 6. Further decreasing the 
ligand donor power by moving to 5 and 10 gave intermediate activity. Only one discernible trend 
emerged: assuming 12 was deprotonated under reaction conditions, one could conclude that LX-type 
chelate ligands are inferior to LL-type combinations. 
 
In view of the surprisingly high performance of the unlinked bis-NHC complex 6, we monitored the 
reaction progress of IrCl3, 1, 3, and 6 by in-situ 1H NMR at lower temperature to compare the effects of 
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introduction of the Cp* and IMe ligands (Figure 7). At 60 ºC, IrCl3 was barely active (20 % conversion 
after 3 hours), but introducing the Cp* ligand (1) caused a marked increase in activity (70 % conversion 
after 3 hours). Further introduction of one IMe ligand to the Cp*Ir fragment (3) decreased activity again, 
whereas introduction of the second IMe ligand (6) boosted catalyst activity to afford full conversion in 
less than 2 hours. This striking difference in performance of 3 and 6 demonstrates that both monodentate 
IMe ligands in 6 are needed for efficient transfer-hydrogenation catalysis and suggests their retention 
during turnover. 
 
 
 
 
 
 
Figure 7. Activity of different iridium precatalysts in the transfer-hydrogenation of acetophenone 
(Scheme 2). Reaction conditions: 0.67 mmol substrate, 1 mol% [Ir], 10 mol% KOH, 1 mL iPrOH, 60 ºC, 
N2 (in-situ 1H NMR analysis with 1,3,5-trimethoxybenzene as internal standard). 
 
We then further explored the transfer-hydrogenation scope of 6. At 1 mol% loading, full conversion of 
various aromatic and aliphatic ketones was achieved within 3 hours at 60 ºC (Table 4). α,β-unsaturated 
ketones (entries 11 & 12) were found to be completely reduced to the saturated alcohols with >90 % 
conversion. In refluxing iso-propanol, 6 still afforded activity at 0.01 mol% loading to reach turnover 
numbers beyond 3000 after 6 hours (entries 3 & 6). 
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Table 4. Performance of precatalyst 6 at different loadings in the transfer-hydrogenation of various 
substrates from iPrOH.a 
entry mol% of 6 substrate conversion TON 
1 b 1.0  99 ± 1 % 99 ± 1 
2 0.1  99 ± 1 % 990 ± 10 
3 c 0.01  31 ± 1 % 3100 ± 100 
4 b 1.0  99 ± 1 % 99 ± 1 
5 0.1  99 ± 1 % 990 ± 10 
6 c 0.01  23 ± 1 % 2300 ± 100 
7 b 1.0 
 
99 ± 1 % 99 ± 1 
 
8 b 1.0 
 
99 ± 1 % 99 ± 1 
9 b 1.0 
 
99 ± 1 % 99 ± 1 
10 b 1.0 
 
99 ± 1 % 99 ± 1 
11 b 1.0 
 
94 ± 1 % d 94 ± 1 (×2) d 
12 b 1.0 
 
95 ± 1 % d 95 ± 1 (×2) d 
 
a 2 mmol substrate, 10 mol% KOH, 3 mL iPrOH, reflux, N2, 3 hours (1H NMR analysis with 1,3,5-trimethoxybenzene as 
internal standard). b at 60 ºC. c after 6 hours. d complete reduction to saturated alcohol. 
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In search of a rationale for the observed ligand effects, the kinetics of the acetophenone reduction with 
6 were investigated. Variation of the KOH loading with 1 mol% [Ir] at 60 ºC showed that the rate was 
clearly base-dependent with slower turnover at lower base loading (Figure 8), but due to the sigmoidal 
shape of the reaction profile, kinetic analysis with respect to the order in base could not be performed. 
As before (Figure 7), a non-productive lag phase of several minutes was always observed which was 
virtually unaffected by the amount of KOH present. Nevertheless, high conversions were still reached 
after longer reaction times at lower base loading, which may be beneficial for the reduction of sensitive 
substrates where time is less important. 
 
 
 
 
 
 
 
Figure 8. Activity of 6 in the transfer-hydrogenation of acetophenone (Scheme 2) at various loadings 
of KOH. Reaction conditions: 2 mmol substrate, 1 mol% [Ir], 3 mL iPrOH, 60 ºC, N2 (1H NMR analysis 
with 1,3,5-trimethoxybenzene as internal standard; lines drawn to guide the eye).  
 
Varying the concentration of 6 at a fixed KOH loading of 10 mol% showed that both the length of the 
non-productive lag phase and the rate of acetophenone reduction were strongly dependent on the iridium 
concentration (Figure 9). 
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Figure 9. Lag phases (stars, right axis) and approximate initial rates (diamonds, left axis) of the 
transfer-hydrogenation of acetophenone (Scheme 2) by 6 at various catalyst loadings. Reaction 
conditions: 0.67 mmol substrate, 10 mol% KOH, 1 mL iPrOH, 60 ºC, N2 (in-situ 1H NMR analysis with 
1,3,5-trimethoxybenzene as internal standard; lines drawn to guide the eye). 
 
The lag phase dependence on [Ir] cleanly followed second order kinetics with an apparent rate 
constant of kobs = 61 µM-1min-1, suggesting a pre-catalytic activation step involving two iridium centers 
(Figure 10). The rates at the onset of catalysis, which could be estimated at 10 mol% base (cf. Figure 8), 
showed two distinct kinetic regimes. Below ~4 µM [Ir], the initial rate of acetophenone reduction after 
the lag phase was clearly dependent on [Ir], whereas at higher concentrations an apparent zero-order 
regime prevailed. Limiting base/Ir ratios were ruled out by testing catalysis at 6.7 µM 6 (= 1 mol%) with 
25 mol% base instead of the usual 10 mol% (as in Figures 7 and 8), which gave no further increase in 
the rate of acetophenone reduction. Therefore, we suspect an [Ir]-dependent catalyst deactivation 
process after pre-activation to be responsible for the apparent rate saturation above ~4 µM [Ir].52 With 
such complex kinetics it is not surprising that our understanding of ligand effects in Cp*Ir precatalysts 
for these transformations is still so limited despite their extensive use. 
 18 
 
 
 
 
 
 
Figure 10. Second-order dependence of the duration of non-productive lag phases in the transfer-
hydrogenation of acetophenone (Scheme 2) by 6 on iridium concentration. Reaction conditions: 0.67 
mmol substrate, 10 mol% KOH, 1 mL iPrOH, 60 ºC, N2 (in-situ 1H NMR analysis with 1,3,5-
trimethoxybenzene as internal standard). 
 
The commonly accepted mechanism of base-assisted transfer-hydrogenations from iso-propanol with 
Cp*Ir complexes follows the so-called ‘monohydride’ route, in which the base shuttles the protic 
hydrogens between the alkoxides and the iridium catalyst delivers the hydrides from the carbinol to the 
carbonyl carbons (Scheme 3).23 
 
Scheme 3. Commonly accepted hydrogen delivery scheme in the monohydride mechanism of base-
assisted transfer-hydrogenation catalysis.23 
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Accordingly, Cp*Ir-monohydride complexes are considered key intermediates in these reactions.18,23 
We thus synthesized the corresponding monohydride complex of 6 by reaction with sodium 
borohydride, which gave the desired compound 6-H as colorless solid in high yield (Scheme 4). The 
complex was found to be air and moisture stable and inert towards reductive elimination of HIMe+ or 
halide exchange with chlorinated solvents at ambient temperature. 
 
Scheme 4. Synthesis of monohydride complex 6-H (see Experimental Section for details). 
 
 
 
 
The 1H NMR resonance of the terminal hydride in 6-H at -16.24 ppm (in CD2Cl2) lies in the expected 
range by comparison with similar complexes reported previously.53-56 Using the same reaction protocol 
with complex 7, only traces of the putative hydride 7-H could be detected by 1H NMR at -15.74 ppm in 
the crude reaction mixture and no stable product could be isolated. Complex 8, however, successfully 
yielded the stable monohydride derivative 8-H (-15.98 ppm)27 after silver-assisted iodide abstraction 
(see Experimental Section). Both 6-H and 8-H proved active in base-assisted transfer-hydrogenation of 
acetophenone (Table 5), in contrast to [Cp*Ir(NHC)(H)2] (-16.9 ppm) and [Cp*Ir(NHC)(µ-H)]2++ (-17.4 
ppm) complexes, which have been reported to be inactive and thus suspected relevant to catalyst 
deactivation pathways.18 The inner-sphere chloride version 8(Cl) of the iodide complex 8 was also 
prepared27 for direct comparison with the chloride complex 6 and their corresponding hydrides. As can 
be seen from Table 5, the more strongly binding iodide had only a small inhibiting effect on activity in 
transfer hydrogenation catalysis. 
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Table 5. Comparison of halide and monohydride complexes in the transfer-hydrogenation of 
acetophenone (Scheme 2).a 
precatalyst conditions conversion 
6(Cl) 
60 ºC, 1 hour 
78 ± 1 % 
6-H 56 ± 1 % 
8(I) 
reflux, 3 hours 
18 ± 2 % 
8(Cl) 43 ± 1 % 
8-H 73 ± 1 % 
 
a 2 mmol substrate, 1 mol% [Ir], 10 mol% KOH, 3 mL iPrOH, N2, (1H NMR analysis with 1,3,5-trimethoxybenzene as 
internal standard). 
 
 
Although this simple activity comparison of halide versus monohydride complexes in case of 6 and 8 
did not allow to comment on their role in the catalytic cycle, it is worth mentioning that the 
monohydrides 10-H (-11.80 ppm)57 and 13-H (-14.98 ppm)58 are also known to be stable but only 10-H 
has been reported to be active in transfer-hydrogenation catalysis.57 Bäckvall’s test for monohydride 
pathways was then applied by following acetophenone reduction from 99 % (CD3)2CD-OH by 1H NMR 
using 6 and 6-H to quantify the degree of H/D scrambling during hydrogen transfer (Scheme 5).22 
 
Scheme 5. Bäckvall’s H/D scrambling test to probe the number of hydrides in the active species of 
transfer-hydrogenation (cf. Scheme 3).22 Note that kinetic isotope effects may lead to > 50 % D transfer 
to the carbinol in the polyhydride mechanism, but would not affect the selectivity of the monohydride 
mechanism.59 
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At 1 mol% [Ir] with 10 mol% KOH at 60 ºC, the chloride complex 6 incorporated 75 % D at the 
carbinol of phenylethanol, whereas for the hydride 6-H 95 % D incorporation at the same position were 
seen by in-situ 1H NMR. In both cases, the levels of product deuteration remained constant throughout 
the reaction up to 90 % conversion as quantified against 1,3,5-trimethoxybenzene as internal standard 
(see Experimental Section for details). Thus, while 6-H gave products consistent with the classic 
monohydride route, 6 gave an inconclusive result as to the number of metal hydrides involved, 
suggesting that 6-H may not be the only possible hydride intermediate in catalysis with 6. 
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CONCLUSION 
We have synthesized and characterized a number of new Cp*Ir complexes bearing combinations of 
pyridine and NHC ligands, and compared their activity in transfer–hydrogenation catalysis to 
structurally related literature compounds under various conditions. Contributions from the base and 
potential heterogeneous forms of iridium have been examined separately, and mercury poisoning 
experiments showed the Cp*Ir systems to be homogeneous. Complex 6 bearing two monodentate IMe 
ligands emerged as the most active precatalyst for the reduction of acetophenone from iso-propanol in 
the presence of KOH, surprisingly superior to its chelating bis-NHC congener. At lower temperatures of 
60˚ C, 6 reduces a variety of ketone substrates with full conversion within two hours, reaching TONs 
>3000 at 0.01 mol% loading. Reaction progress monitoring in comparison with the mono-NHC complex 
3 showed that both NHCs are needed for efficient catalysis. The kinetics of the catalysis with 6 were 
complex, showing a bimolecular activation period followed by base-dependent hydrogen-transfer 
catalysis with an apparent rate saturation at [Ir] concentrations >4 µM. A stable monohydride derivative 
of 6 has been synthesized which is active in the reaction, but H/D scrambling data suggest that it may 
not be the only intermediate in the catalytic cycle. Although the mechanistic reason for the superiority of 
6 and the role of the monohydride in catalysis remain to be examined further in a following report, the 
present work provides important insight into this basic transformation and sheds some light on ligand 
effects in these widely used Cp*Ir precatalysts. 
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EXPERIMENTAL SECTION 
General. Organic solvents were purified by passing over activated alumina with dry N2. All chemicals 
were purchased from major commercial suppliers and used as received. Syntheses were performed under 
an inert atmosphere of dry N2 using standard Schlenk techniques. NMR spectra were recorded on either 
400 MHz or 500 MHz Bruker Avance spectrometers and referenced to residual protio-solvent signals. 
The chemical shift δ is reported in units of parts per million (ppm). MS analyses were performed by the 
Mass Spectrometry and Proteomics Resource of the W.M. Keck Foundation Biotechnology Resource 
Laboratory at Yale University. [1,3-dimethylimidazolium]BF4 and [1,4-dimethyl-1,2,4-triazolium]BF4,60 
[Cp*IrCl2]2 (1),61 [Cp*Ir(IMe)Cl2] (3),26 [Cp*Ir(bis-IMe)I]PF6 (8),27 [Cp*Ir(bis-TMe)I]PF6 (9),62 
[Cp*Ir(bipy)Cl]BF4 (10),28 rac-[Cp*Ir(py-IMe)Cl]BF4 (11),26 [Cp*Ir(biim)Cl]BF4 (12),31 rac-
[Cp*Ir(bequi)Cl] (13),29 and rac-[Cp*Ir(phe-IPh)Cl] (14)30 were synthesized via slightly modified 
literature procedures. Single crystals suitable for X-ray crystallography were obtained by diffusion of 
Et2O into concentrated CH2Cl2 solutions at room temperature. Details of the X-ray diffraction 
experiments can be found in the Supporting Information. 
 
[(η5-pentamethylcyclopentadienyl)IrIII(κN-pyridine)Cl2] (2). [Cp*IrCl2]2 (120 mg, 0.15 mmol) was 
dissolved in CH2Cl2 (10 mL) and pyridine (24 mg, 0.3 mmol) added, causing an immediate color change 
from orange to yellow. After stirring at room temperature for 15 minutes the solvent was evaporated 
under reduced pressure, yielding a yellow-orange powder that did not change color upon drying in 
vacuo. Yield = 140 mg (98 %). 1H-NMR (400 MHz, CD2Cl2): δ = 8.92 (dd, J = 6.5 Hz, J = 1.6 Hz, 2H, 
o-CHpy), 7.77 (tt, J = 7.7 Hz, J = 1.6 Hz, 1H, p-CHpy), 7.37 (ddd, J = 7.7 Hz, J = 6.5 Hz, J = 1.6 Hz, 2H, 
m-CHpy), 1.49 (s, 15H, C5(CH3)5). 13C{1H}-NMR (100 MHz, CD2Cl2): δ = 153.7 (s, o-CHpy), 138.3 (s, 
p-CHpy), 125.9 (s, m-CHpy), 86.1 (s, C5(CH3)5), 8.6 (s, C5(CH3)5). ESI(+)MS calcd for C15H20ClIrN+ (2 - 
Cl): 440.089, 442.091. Found: m/z = 440.318, 442.313. 
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rac-[(η5-pentamethylcyclopentadienyl)IrIII(κC-1,3-dimethylimidazol-2-ylidene)(κN-
pyridine)Cl]BF4 (4). [Cp*Ir(IMe)Cl2] (3, 99 mg, 0.2 mmol) was dissolved in CH2Cl2 (10 mL) and 
pyridine (19 mg, 0.24 mmol) added. Upon addition of AgBF4 (39 mg, 0.2 mmol) in MeOH (1 mL) the 
mixture turned bright yellow with immediate precipitation of a colorless solid. After stirring at room 
temperature for one hour the solid was filtered off, discarded, and the clear solution dried in vacuo to 
leave a yellow solid. Recrystallization from acetone/Et2O gave yellow microcrystals. Yield = 106 mg 
(85 %). 1H-NMR (400 MHz, CD2Cl2): δ = 8.46 (d, J = 5.3 Hz, 2H, o-CHpy), 7.93 (t, J = 7.4 Hz, 1H, p-
CHpy), 7.40 (t, J = 6.7 Hz, 2H, m-CHpy), 7.13 (s, 2H, NCHCHN), 3.51 (bs, 6H, NCH3), 1.66 (s, 15H, 
C5(CH3)5). 13C{1H}-NMR (100 MHz, CD2Cl2): δ = 155.0 (s, o-CHpy), 154.4 (s, NCN), 139.2 (s, p-
CHpy), 127.3 (s, m-CHpy), 125.0 (s, NCHCHN), 91.9 (s, C5(CH3)5), 38.2 (s, NCH3), 9.5 (s, C5(CH3)5). 
ESI(+)MS calcd for C15H23ClIrN2+ (4 - BF4 - pyridine): 457.115, 459.117. Found: m/z = 457.351, 
459.351. Crystal data [CCDC-961097]: C20H28BClF4IrN3 (4), M = 624.941, monoclinic, P21/c, a = 
8.9512(10) Å, b = 24.437(3) Å, c = 10.4956(11) Å, β = 95.799(7)°, V = 2284.1(4) Å3, Z = 4, dcalc = 
1.817 g/cm3, T = 223 K, 21642 reflections collected, 5195 independent reflections (Rint = 0.0747), final 
R1 = 0.0490, final wR2 = 0.0567, GOF = 1.066. 
 
[(η5-pentamethylcyclopentadienyl)IrIIIbis-(κN-pyridine)Cl]BF4 (5). [Cp*IrCl2]2 (80 mg, 0.1 mmol) 
was dissolved in CH2Cl2 (5 mL) and pyridine (32 mg, 0.4 mmol) added, causing an immediate color 
change from orange to yellow. Upon addition of AgBF4 (39 mg, 0.2 mmol) in MeOH (1 mL) a colorless 
solid precipitated instantly. After stirring at room temperature for 15 minutes the solid was filtered off, 
discarded, and the clear solution dried in vacuo to leave a yellow solid. Recrystallization from 
CH2Cl2/Et2O gave bright yellow microcrystals. Yield = 108 mg (89 %). 1H-NMR (400 MHz, CD2Cl2): δ 
= 8.95 (d, J = 5.1 Hz, 4H, o-CHpy), 7.91 (t, J = 7.6 Hz, 2H, p-CHpy), 7.54 (t, J = 7.0 Hz, 4H, m-CHpy), 
1.49 (s, 15H, C5(CH3)5). 13C{1H}-NMR (100 MHz, CD2Cl2): δ = 153.3 (s, o-CHpy), 139.9 (s, p-CHpy), 
127.5 (s, m-CHpy), 89.0 (s, C5(CH3)5), 8.6 (s, C5(CH3)5). ESI(+)MS calcd for C15H20ClIrN+ (5 - BF4 - 
pyridine): 440.089, 442.091. Found: m/z = 440.081, 442.082. Crystal data [CCDC-961098]: 
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C20H25BClF4IrN2 (5), M = 607.910, monoclinic, P21/c, a = 9.2867(17) Å, b = 14.334(3) Å, c = 
16.829(3) Å, β = 90.266(5)°, V = 2240.1(7) Å3, Z = 4, dcalc = 1.802 g/cm3, T = 223 K, 14993 reflections 
collected, 4952 independent reflections (Rint = 0.0374), final R1 = 0.0336, final wR2 = 0.0661, GOF = 
1.083. 
 
[(η5-pentamethylcyclopentadienyl)IrIIIbis-(κC-1,3-dimethylimidazol-2-ylidene)Cl]BF4 (6). 
[Ag(IMe)2]BF4 was prepared as a colorless crystalline solid from [1,3-dimethylimidazolium]BF4, 
NaOH, and Ag2O as described previously.25 [Cp*IrCl2]2 (159 mg, 0.2 mmol) and [Ag(IMe)2]BF4 (155 
mg, 0.4 mmol) were dissolved in dry CH2Cl2 (10 mL), and the resulting orange suspension stirred for 
one hour at room temperature. The colorless precipitate was filtered off, the solution concentrated to ~4 
mL under reduced pressure, and filtered again through 0.2 µm pore size Teflon filter. Addition of Et2O 
(15 mL) caused precipitation of a yellow-orange powder, which was collected and dried in vacuo. Yield 
= 234 mg (91 %). 1H-NMR (400 MHz, CD2Cl2): δ = 7.08 (s, 4H, NCHCHN), 3.44 (s, 12H, NCH3), 1.64 
(s, 15H, C5(CH3)5). 13C{1H}-NMR (100 MHz, CD2Cl2): δ = 147.5 (s, NCN), 124.4 (s, NCHCHN), 96.1 
(s, C5(CH3)5), 38.6  (s, NCH3), 10.6 (s, C5(CH3)5). ESI(+)MS calcd for C20H31ClIrN4+ (6 - BF4): 
553.184, 555.186. Found: m/z = 553.117, 555.126. Crystal data [CCDC-961595]: C20H31BClF4IrN4 (6), 
M = 641.972, monoclinic, P21/n, a = 9.6053(10) Å, b = 17.4146(17) Å, c = 14.7645(15) Å, β = 
102.613(3)°, V = 2410.1(4) Å3, Z = 4, dcalc = 1.769 g/cm3, T = 223 K, 24506 reflections collected, 5484 
independent reflections (Rint = 0.0397), final R1 = 0.0405, final wR2 = 0.0834, GOF = 1.075. 
 
[(η5-pentamethylcyclopentadienyl)IrIIIbis-(κC-1,4-dimethyl-1,2,4-triazol-5-ylidene)Cl]BF4 (7). 
[Ag(TMe)2]BF4 was prepared as a colorless crystalline solid from [1,4-dimethyl-1,2,4-triazolium]BF4, 
NaOH, and Ag2O as described previously for imidazole-2-ylidenes.25 [Cp*IrCl2]2 (80 mg, 0.1 mmol) 
and [Ag(TMe)2]BF4 (78 mg, 0.2 mmol) were dissolved in dry CH2Cl2 (5 mL), and the resulting orange 
suspension stirred for six hours at room temperature. The colorless precipitate was filtered off, the 
solution concentrated to ~2 mL under reduced pressure, and filtered again through 0.2 µm pore size 
 26 
Teflon filter. Addition of Et2O (10 mL) caused precipitation of a yellow-orange powder, which was 
collected and dried in vacuo. Yield = 113 mg (88 %). 1H-NMR (400 MHz, CD2Cl2): δ = 8.22 (s, 2H, 
NCHN), 3.85 (s, 6H, NCH3), 3.40 (s, 6H, NCH3), 1.70 (s, 15H, C5(CH3)5). 13C{1H}-NMR (125 MHz, 
CD2Cl2): δ = 151.4 (s, NCN), 145.7 (s, NCHN), 96.5 (s, C5(CH3)5), 40.3 (s, NCH3), 35.5 (s, NCH3), 
10.1 (s, C5(CH3)5). ESI(+)MS calcd for C18H29ClIrN6+ (7 - BF4): 555.174, 557.177. Found: m/z = 
555.411, 557.399. Crystal data [CCDC-961099]: C20H20BClF4IrN6 (7), M = 658.898, triclinic, P-1, a = 
9.5222(17) Å, b = 10.0943(18) Å, c = 12.105(2) Å, α = 88.626(5)°, β = 81.821(5)°, γ = 87.868(5)°, V = 
1150.7(4) Å3, Z = 2, dcalc = 1.902 g/cm3, T = 223 K, 11267 reflections collected, 4849 independent 
reflections (Rint = 0.0367), final R1 = 0.0410, final wR2 = 0.0710, GOF = 1.155. 
 
[(η5-pentamethylcyclopentadienyl)IrIIIbis-(κC-1,3-dimethylimidazol-2-ylidene)H]BF4 (6-H). 6 
(128 mg, 0.2 mmol) and NaBH4 (76 mg, 2 mmol) were placed in a flame-dried Schlenk flask under N2 
and dry iso-propanol (10 mL) was added. The mixture was sonicated for five minutes and then stirred 
for another hour at room temperature. All volatiles were removed under reduced pressure to leave a 
beige solid, which was dried further in vacuo. The residue was extracted with CH2Cl2 (6 mL), the 
extract filtered through 0.2 µm pore size Teflon filter, and the pale yellow solution reduced to ~3 mL 
volume under reduced pressure. Addition of Et2O (10 mL) caused precipitation of a very fine colorless 
solid, which was collected, washed with Et2O (4 mL), and dried in vacuo. Yield = 110 mg (91 %). 1H-
NMR (500 MHz, CD2Cl2): δ = 7.02 (s, 4H, NCHCHN), 3.54 (s, 12 H, NCH3), 1.93 (s, 15H, C5(CH3)5), -
16.24 (s, 1H, IrH). 13C{1H}-NMR (125 MHz, CD2Cl2): δ = 149.9 (d, J = 5.2 Hz, NCN), 121.9 (s, 
NCHCHN), 92.8 (s, C5(CH3)5), 39.1  (s, NCH3), 10.5 (s, C5(CH3)5). ESI(+)MS calcd for C20H32IrN4+ (6-
H - BF4): 519.223, 521.225. Found: m/z = 519.219, 521.223. 
 
[(η5-pentamethylcyclopentadienyl)IrIII(κC,κC’-1,1'-methylene-bis(3-methylimidazolidin-2-
ylidene))H]BF4 (8-H). This compound has previously been obtained via a different synthetic route.27 8 
(78 mg, 0.1 mmol) and AgPF6 (26 mg, 0.11 mmol) placed in a flame-dried Schlenk flask under N2 and 
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MeCN added (3 mL). NaBH4 (38 mg, 1 mmol) and iso-propanol were then added, and the mixture 
stirred at 50 ˚C for two hours. After cooling to room temperature the mixture was filtered, and the pale 
yellow solution taken to dryness in vacuo. The solid residue was extracted with CH2Cl2 (4 mL) and 
filtered through 0.2 µm pore size Teflon filter. Addition of Et2O (12 mL) caused precipitation of a pale 
yellow powder, which was collected, washed with Et2O (3 mL), and dried in vacuo. Yield = 39 mg (60 
%). 1H-NMR (400 MHz, CD2Cl2): δ = 7.36 (d, J = 1.8 Hz, 2H, NCHCHN), 6.99 (d, J = 1.8 Hz, 2H, 
NCHCHN), 6.15 (d, J = 12.7 Hz, 1H, NCH2N), 5.36 (d, J = 12.7 Hz, 1H, NCH2N), 3.57 (s, 6H, NCH3), 
2.00 (s, 15H, C5(CH3)5), -15.98 (s, 1H, IrH). 
 
Iridium(0) Nanoparticles. 2-3 nm Ir NPs were prepared using an adaption of a reported method.48 
[(coe)2IrCl]2 (9 mg, 0.01 mmol) in dry iso-propanol (3 mL) was stirred under an atmosphere of H2 at 
60 ºC until a greyish solution was obtained (15-30 minutes). At this point the atmosphere was 
exchanged to N2, and the solution directly used for transfer-hydrogenation catalysis. 
 
Catalysis. All complexes used in catalysis were freshly purified prior to use. Complexes 827 and 962 
were purified by recrystallization from chloroform at -78 °C, and complex 1430 by column 
chromatography as described in the original publications. All others were purified by dissolution in a 
minimum amount of CH2Cl2, filtration through hydrophobic 0.2 µm Teflon filter, and recrystallization 
by addition of Et2O as described in the synthesis part. Catalytic runs were performed by charging a 
flame-dried Schlenk flask with 20 µmol Ir-complex and 0.2 mmol 1,3,5-trimethoxybenzene (TMB) as 
internal standard under N2 and adding 2 mL dry iso-propanol. After heating to the desired reaction 
temperature liquid substrate (2 mmol acetophenone) and base (0.2 mmol KOH, semiconductor grade) 
were added in 1 mL dry iso-propanol to start the reaction. Aliquots were withdrawn by syringe and 
quenched by mixing with CDCl3 in air at room temperature. After filtration through celite the solution 
was analyzed for conversion by 1H NMR. In-situ NMR reaction progress monitoring was performed in 
screw-capped 5 mm tubes, charged with solid iridium complex (0.007 mmol) and 1,3,5-
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trimethoxybenzene (0.067 mmol) under N2. A solution of KOH (0.067 mmol) in dry iso-propanol (1 
mL) was added, followed by acetophenone (78 μL, 0.67 mmol). The NMR tube was sonicated for 30 
seconds, placed in the NMR spectrometer with the probe preheated to 60 ºC, and 1H NMR spectra 
acquired every 2 minutes. 
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